CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.

China Chemical & Pharmaceutical Co., Ltd.

1701

TW0001701001

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
22.25 ^TWD	-0.22%		-0.89%	-8.62%

Jul. 04	China Chemical & Pharmaceutical Co., Ltd. Approves Cash Dividend, Payable on August 20, 2024	CI
May. 28	China Chemical & Pharmaceutical Co., Ltd. Announces Cenra Inc Appoints Wang Hsieh, I-Chen as Chairman of the Board of Directors, Effective September 2, 2024	CI

China Chemical & Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021

May 26, 2022 at 06:51 am EDT

China Chemical & Pharmaceutical Co., Ltd. at its 2022 annual shareholders meeting held on May 26, 2022, approved cash dividend was TWD 268,272,972 (TWD 0.9 per share) for 2021.

Latest news about China Chemical & Pharmaceutical Co., Ltd.

China Chemical & Pharmaceutical Co., Ltd. Approves Cash Dividend, Payable on August 20, 2024	Jul. 04	CI
China Chemical & Pharmaceutical Co., Ltd. Announces Cenra Inc Appoints Wang Hsieh, I-Chen as Chairman of the Board of Directors, Effective September 2, 2024	May. 28	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 31	CI
China Chemical & Pharmaceutical Co., Ltd. Proposes Dividend Distribution for the Year Ended December 31, 2023	Mar. 11	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
China Chemical & Pharmaceutical Co., Ltd. Approves Cash Dividend, Payable on August 22, 2023	23-06-29	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
China Chemical & Pharmaceutical Co., Ltd. Proposes Dividend Distribution for the Fiscal Year 2022	23-03-07	CI
China Chemical & Pharmaceutical Co., Ltd. announced a financing transaction	23-03-06	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company	22-07-14	CI
MegaPro Biomedical, Two Others Form Non-Invasive Drug Development JV	22-07-12	MT
Creso Pharma Limited Secures Non-Binding, Non-Exclusive Heads of Agreement with China Chemical & Pharmaceutical Co., Ltd	22-06-29	CI
China Chemical & Pharmaceutical Co., Ltd. Announces Cash Dividends to Shareholders, Payable on August 19, 2022	22-06-28	CI
China Chemical & Pharmaceutical Co., Ltd. Appoints Leu,Chia-Hwel as Member of the Compensation Committee	22-05-26	CI
China Chemical & Pharmaceutical Co., Ltd. Elects Leu,Chia-Hwel as Independent Director	22-05-26	CI
China Chemical & Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021	22-05-26	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
China Chemical & Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year Ended December 31, 2021	22-03-08	CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-11	CI

Chart China Chemical & Pharmaceutical Co., Ltd.

Duration

Period

Chart China Chemical & Pharmaceutical Co., Ltd.

More charts

CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. is a Taiwan-based company principally engaged in the manufacture and sales of pharmaceuticals. The products of the Company include pharmaceuticals for human, animal drugs, medical devices, daily products and nutritious food products. Pharmaceuticals for human include prescription drugs and patented medicines, among others. Medical equipment includes nursing liquid for contact lens, sphygmomanometers and manmade joints. Animal drugs include feedstuff additives and healthcare products for animals, among others. Daily products include toothpastes, shower liquid, facial masks and mouth rinses, among others. The Company operates businesses in Taiwan and Mainland China.

Sector

Pharmaceuticals

Calendar

2024-08-06 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.	-8.62%	203M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+25.40%	45.54B
OTSUKA HOLDINGS CO., LTD.	+34.52%	24.51B
SANDOZ GROUP AG	+27.12%	16.48B
CIPLA LIMITED	+21.19%	14.66B
ZYDUS LIFESCIENCES LIMITED	+71.91%	14.3B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.84%	6.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.08%	5.87B
STADA ARZNEIMITTEL	-8.87%	5.73B